Detalles de la búsqueda
1.
Non-coding recurrent mutations in chronic lymphocytic leukaemia.
Nature
; 526(7574): 519-24, 2015 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26200345
2.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548583
3.
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Br J Haematol
; 185(3): 480-491, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30793290
4.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Haematologica
; 103(8): 1351-1358, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748443
5.
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
Blood Adv
; 7(23): 7384-7391, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37505099
6.
Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma.
Leuk Lymphoma
; 44(3): 459-64, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12688315
7.
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
J Clin Oncol
; 26(16): 2737-44, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18443352
Resultados
1 -
7
de 7
1
Próxima >
>>